Clinical characteristics and changes of myocardial injury markers in COVID-19 patients

Clinical characteristics and changes of myocardial injury markers in COVID-19 patients

Objective To analyze the clinical characteristics of COVID-19 patients and the changes in their myocardial biomarkers.Methods The clinical data of COVID-19 patients admitted to the First People's Hospital of Jiangxia District in Wuhan, China, from February 1, 2020, to March 15, 2020, were re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jin-Hui ZHANG, Liu-Sheng XU, Yu-Meng GUO, Jian-Guo ZHANG, Zhi-Min TAO
Format:	Article
Language:	zho
Published:	Editorial Office of New Medicine 2021-10-01
Series:	Yixue xinzhi zazhi
Subjects:	sars-cov-2 covid-19 myocardial biomarkers ace2
Online Access:	https://yxxz.whuznhmedj.com/storage/attach/2110/fKoqOwAPRfJlmnm9TPXjyxOzqEw84REF0hudSPde.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The protein expression profile of ACE2 in human tissues
by: Feria Hikmet, et al.
Published: (2020-07-01)

Oxidative Stress and Its Association with COVID-19: A Narrative Review
by: Hardi Rafat Baqi, et al.
Published: (2020-06-01)

Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1
by: Nianzhen Chen, et al.
Published: (2024-10-01)

Venom Peptides of Crotalus atrox Against SARS-Cov-2 Spike Protein and Human ACE2 Receptor by Molecular Docking Analysis
by: Süleyman İlhan
Published: (2023-08-01)

Autoantibodies in COVID-19: implications for disease severity and clinical outcomes
by: Yannick Galipeau, et al.
Published: (2025-01-01)

Designing of an innovative conserved multiepitope subunit vaccine targeting SARS-CoV-2 glycoprotein and nucleoprotein through immunoinformatic
by: Temitope Isaac Adelusi, et al.
Published: (2025-01-01)

Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 spike proteins with human ACE2 receptor
by: Acharya Balkrishna, et al.
Published: (2025-02-01)

Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemicResearch in context
by: Anouschka Akerman, et al.
Published: (2024-12-01)

Association of <i>ACE2</i> Gene Variants with Adverse Perinatal Outcomes in COVID-19 Infected Pregnant Women in Kazakhstan
by: Kymbat Mukhtarova, et al.
Published: (2024-10-01)

Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain
by: Xiao Niu, et al.
Published: (2024-12-01)

Druggability and molecular docking of essential secondary metabolites from Azadirachta indica leaf against angiotensin converting enzyme-2: Covid-19 in focus
by: Paul Chijioke Ozioko, et al.
Published: (2025-02-01)

Sitagliptin: a potential drug for the treatment of COVID-19?
by: Bardaweel Sanaa K., et al.
Published: (2021-06-01)

Methylene Blue Has Strong Extracellular Virucidal Activity Against a SARS-CoV-2-Related Pangolin Coronavirus with No Intracellular or In Vivo Efficacy
by: Lai Wei, et al.
Published: (2024-11-01)

Effectiveness of COVID-19 vaccination among patients hospitalized from April 2020 to March 2021: A Retrospective cohort study
by: Nehal Khater, et al.
Published: (2024-05-01)

The Immunologic Downsides Associated with the Powerful Translation of Current COVID-19 Vaccine mRNA Can Be Overcome by Mucosal Vaccines
by: Maurizio Federico
Published: (2024-11-01)

The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
by: Zhen Zhang, et al.
Published: (2024-12-01)

Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study
by: Andrea Alemany, et al.
Published: (2024-11-01)

Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice
by: Mayara Mattos, et al.
Published: (2024-11-01)

Ferritin at admission as a prognostic marker in older adults hospitalized for COVID-19: A retrospective cohort study
by: Janet Ramírez Torres, et al.
Published: (2024-12-01)

Regulation of Paneth cell-specific genes in COVID-19 patients and SARS-CoV-2-infected mice by quantification of mRNA from exfoliated cells in stool samples
by: Gill Diamond, et al.
Published: (2024-12-01)

Elimination of olfactory sensory neurons by zinc sulfate inoculation prevents SARS-CoV-2 infection of the brain in K18-hACE2 transgenic mice
by: Ji-Hun Lee, et al.
Published: (2024-11-01)

Daphnetin may protect from SARS-CoV-2 infection by reducing ACE2
by: Qian-wen Yang, et al.
Published: (2024-12-01)

Association of Single-Nucleotide Variants in ACE2 with the Persistence of Positive qPCR Test for SARS-CoV-2 in Healthcare Professionals During the First Wave of the COVID-19 Pandemic
by: Karina Jiménez-Gil, et al.
Published: (2024-12-01)

Serum-soluble ST2 as a novel biomarker for COVID-19 severity and mortality: A systematic review and meta-analysis
by: Kacper DZIEDZIC, et al.
Published: (2024-03-01)

SARS CoV-2 in tumor tissue in glioblastoma patients – preliminary study
by: Brzozowski Michal, et al.
Published: (2024-12-01)

State of Knowledge About Thyroid Cancers in the Era of COVID-19—A Narrative Review
by: Agnieszka Bronowicka-Szydełko, et al.
Published: (2024-12-01)

Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2
by: Mariyana Atanasova, et al.
Published: (2024-11-01)

Inflammatory discoveries two years after acute severe COVID-19: a longitudinal biomarker profile assessment in long COVID individuals in the Brazilian Amazon
by: Alex Bezerra Silva Maciel, et al.
Published: (2024-12-01)

SARS-CoV-2 Induced Interleukin -18 Response among Presumptive Covid-19 Patients in Kano State, Nigeria
by: Sanusi, U. I., et al.
Published: (2024-06-01)

The inactivation of the Niemann Pick C1 cholesterol transporter restricts SARS-CoV-2 entry into host cells by decreasing ACE2 abundance at the plasma membrane
by: Piergiorgio La Rosa, et al.
Published: (2024-12-01)

The Impact of COVID-19 Vaccination on Oxidative Stress and Cardiac Fibrosis Biomarkers in Patients with Acute Myocardial Infarction (STEMI), a Single-Center Experience Analysis
by: Razan Al Namat, et al.
Published: (2024-10-01)

Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: a Paradigmatic Case.
by: Giacomo Marchi, et al.
Published: (2020-08-01)

Comparing myocardial perfusion scan findings in patients with and without Covid-19
by: Bahar Moasses-Ghafari, et al.
Published: (2025-01-01)

Research progress of SARS-CoV-2 and COVID-19
by: Nan CHEN, et al.
Published: (2021-06-01)

Metabolomic Profiling Reveals Potential Biomarkers and Prominent Features in HIV/AIDS Patients Co-Infected with SARS-CoV-2
by: Xuan Yan, et al.
Published: (2025-01-01)

Severe headache as the first presentation of post-COVID-19 brain and spinal cord injury resembling neurosarcoidosis
by: Asieh Mehramiri, et al.
Published: (2024-11-01)

A neglected complication of COVID-19: liver injury
by: Tian LAN, et al.
Published: (2021-03-01)

Clinicopathological Features of Cutaneous Findings of SARS-CoV-2 Infection
by: Bengu COBANOGLU, et al.
Published: (2022-09-01)

The role of COX2 deficiency attenuates cardiac damage in acute myocardial infarction
by: Jing Zhu, et al.
Published: (2024-11-01)

Dynamics of coagulation proteins upon ICU admission and after one year of recovery from COVID-19: a preliminary study
by: Raquel Behar-Lagares, et al.
Published: (2025-01-01)